Defective Zn Homeostasis impairs host defense against pneumococcal pneumonia

锌稳态缺陷会损害宿主对肺炎球菌肺炎的防御能力

基本信息

  • 批准号:
    10365619
  • 负责人:
  • 金额:
    $ 38.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-12-22 至 2025-11-30
  • 项目状态:
    未结题

项目摘要

Community acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Streptococcus pneumoniae (pneumococcus) remains the most common cause of CAP in the U.S. The incidence of CAP continues to rise contributing to increased hospitalization and mortality. A major cause of CAP is decline in immune function in vulnerable populations. Zinc (Zn) is required for proper immune function and insufficient dietary intake is highly prevalent within vulnerable populations. Zn deficient subjects are more susceptible to pathogens and have a higher incidence of pneumonia whereas Zn supplementation reduces the incidence of pneumonia. The long-term goal of this project is to determine the role of the human zinc transporter ZIP8 and dietary Zn intake in the host immune response to pneumococcal pneumonia. Our group was the first to reveal that ZIP8 is required for myeloid cell activation following exposure to bacteria. This is relevant because a relative deficit of Zn, either by dietary restriction or deficits in ZIP8-mediated Zn transport, in the setting of the host response to bacterial invasion in the lung leads to immune dysfunction, increased lung damage, and higher mortality (see preliminary data). We hypothesize that ZIP8 plays a pivotal role in lung macrophages and dendritic cells by maintaining favorable balance of both the innate and adaptive immune response. Accordingly, defective Zn intake or ZIP8 function prohibits the ability of Zn to facilitate normal immune function and host defense. If proven correct, this will have important implications on pneumonia pathogenesis and increase our capacity to predict disease susceptibility and prevent morbidity and mortality. Guided by strong preliminary evidence, this hypothesis will be tested by pursuing three specific aims that will: 1) Determine the impact of ZIP8 loss on the lung myeloid landscape in vivo and its impact on pathogen clearance and host survival; 2) Determine how ZIP8 impacts Macrophage and DC function; and 3) Determine the impact of Zn supplementation on pneumococcal pneumonia in vivo in the setting of Zn dyshomeostasis. To accomplish our goals we have assembled a strong and experienced team that will pursue novel studies in two novel knockout mouse models and a model of dietary Zn restriction that will explore the role of the zinc transporter protein ZIP8 in maintaining myeloid cell-driven immune balance in the setting pneumococcal pneumonia. At the successful completion of this study, we will better understand the interplay between Zn homeostasis and ZIP8 in the context of pneumococcal infection in the lung. This is expected to have a positive impact because it will reveal previously unidentified molecular pathways that are instrumental in host defense. Further, we have the potential to identify novel micronutrient and genetic surveillance as well as treatment strategies that will improve our ability to prevent pneumococcal pneumonia in the most vulnerable populations worldwide. We envision that this will also lend itself to new approaches to treat or prevent other harmful pathogens.
社区获得性肺炎(CAP)是世界范围内发病率和死亡率的主要原因。链球菌

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAREN Lee KNOELL其他文献

DAREN Lee KNOELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAREN Lee KNOELL', 18)}}的其他基金

Defective Zn Homeostasis impairs host defense against pneumococcal pneumonia
锌稳态缺陷会损害宿主对肺炎球菌肺炎的防御能力
  • 批准号:
    10543428
  • 财政年份:
    2021
  • 资助金额:
    $ 38.3万
  • 项目类别:
Role of ZIP8 in secondary cigarette smoke exposure-mediated lung injury
ZIP8 在继发性香烟烟雾暴露介导的肺损伤中的作用
  • 批准号:
    9397646
  • 财政年份:
    2016
  • 资助金额:
    $ 38.3万
  • 项目类别:
Role of ZIP8 in first hand cigarette smoke exposure-mediated lung injury
ZIP8 在第一手香烟烟雾暴露介导的肺损伤中的作用
  • 批准号:
    8787779
  • 财政年份:
    2014
  • 资助金额:
    $ 38.3万
  • 项目类别:
Role of ZIP8 in first hand cigarette smoke exposure-mediated lung injury
ZIP8 在第一手香烟烟雾暴露介导的肺损伤中的作用
  • 批准号:
    8630038
  • 财政年份:
    2014
  • 资助金额:
    $ 38.3万
  • 项目类别:
Role of ZIP8 in first hand cigarette smoke exposure-mediated lung injury
ZIP8 在第一手香烟烟雾暴露介导的肺损伤中的作用
  • 批准号:
    8986202
  • 财政年份:
    2014
  • 资助金额:
    $ 38.3万
  • 项目类别:
The cytoprotective role of zinc transporters in human lung epithelia
锌转运蛋白在人肺上皮细胞中的细胞保护作用
  • 批准号:
    8044007
  • 财政年份:
    2007
  • 资助金额:
    $ 38.3万
  • 项目类别:
The cytoprotective role of zinc transporters in human lung epithelia
锌转运蛋白在人肺上皮细胞中的细胞保护作用
  • 批准号:
    7393145
  • 财政年份:
    2007
  • 资助金额:
    $ 38.3万
  • 项目类别:
The cytoprotective role of zinc transporters in human lung epithelia
锌转运蛋白在人肺上皮细胞中的细胞保护作用
  • 批准号:
    7266785
  • 财政年份:
    2007
  • 资助金额:
    $ 38.3万
  • 项目类别:
The cytoprotective role of zinc transporters in human lung epithelia
锌转运蛋白在人肺上皮细胞中的细胞保护作用
  • 批准号:
    7588768
  • 财政年份:
    2007
  • 资助金额:
    $ 38.3万
  • 项目类别:
Cytolytic Attack Against Lung Parenchyma in Emphysema
肺气肿中对肺实质的细胞溶解攻击
  • 批准号:
    6621326
  • 财政年份:
    2002
  • 资助金额:
    $ 38.3万
  • 项目类别:

相似海外基金

The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 38.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
  • 批准号:
    MR/X005046/1
  • 财政年份:
    2023
  • 资助金额:
    $ 38.3万
  • 项目类别:
    Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
  • 批准号:
    23H03154
  • 财政年份:
    2023
  • 资助金额:
    $ 38.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
  • 批准号:
    10607319
  • 财政年份:
    2023
  • 资助金额:
    $ 38.3万
  • 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
  • 批准号:
    471247
  • 财政年份:
    2022
  • 资助金额:
    $ 38.3万
  • 项目类别:
    Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
  • 批准号:
    485971
  • 财政年份:
    2022
  • 资助金额:
    $ 38.3万
  • 项目类别:
    Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
  • 批准号:
    22K06698
  • 财政年份:
    2022
  • 资助金额:
    $ 38.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
  • 批准号:
    462596862
  • 财政年份:
    2021
  • 资助金额:
    $ 38.3万
  • 项目类别:
    WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
  • 批准号:
    21K16251
  • 财政年份:
    2021
  • 资助金额:
    $ 38.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
  • 批准号:
    NC/V001019/1
  • 财政年份:
    2021
  • 资助金额:
    $ 38.3万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了